| Unichem Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506690 |
NSE Symbol : UNICHEMLAB |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE351A01035 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 373.14 |
Market Cap(₹Cr) : 3,659.69 |
Face Value(₹) : 2.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,412.29 | 1,735.70 | 1,442.16 | 1,072.43 | 942.93 |
| Other Income | 363.54 | 44.83 | 98.40 | 41.85 | 42.07 |
| Stock Adjustments | 7.28 | 33.33 | 26.35 | -22.01 | 52.79 |
| Total Income | 1,783.11 | 1,813.86 | 1,566.91 | 1,092.27 | 1,037.79 |
| EXPENDITURE : | |||||
| Raw Materials | 672.64 | 830.62 | 717.82 | 501.86 | 436.27 |
| Power and Fuel Cost | 105.32 | 106.63 | 105.64 | 101.41 | 77.12 |
| Other Manufacturing Expenses | 95.42 | 78.10 | 74.62 | 70.61 | 73.49 |
| Selling and Administration Expenses | 195.50 | 190.81 | 213.59 | 194.89 | 192.65 |
| Miscellaneous Expenses | 96.77 | 21.48 | 148.40 | 116.36 | 8.95 |
| Employee Benefit Expenses | 277.22 | 287.51 | 283.15 | 270.86 | 250.79 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 340.24 | 298.71 | 23.69 | -163.73 | -1.49 |
| Interest | 11.80 | 7.62 | 10.42 | 9.38 | 2.07 |
| Gross Profit | 328.44 | 291.09 | 13.27 | -173.11 | -3.56 |
| Depreciation | 119.03 | 108.41 | 105.45 | 105.98 | 83.19 |
| Profit Before Tax | 209.41 | 182.68 | -92.18 | -279.09 | -86.75 |
| Current Tax | 0.44 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 50.03 | 19.72 | 0.00 | 20.61 | -31.32 |
| Reported Net Profit | 158.94 | 162.96 | -92.18 | -299.70 | -55.43 |
| Extraordinary Items | 174.51 | 4.42 | -55.94 | -103.16 | -0.25 |
| Adjusted Net Profit | -15.57 | 158.54 | -36.24 | -196.54 | -55.18 |
| Adjustment below Net Profit | -1.38 | 0.00 | 0.00 | 121.81 | 0.00 |
| Profit/Loss Balance carried down | 2,445.03 | 2,279.18 | 2,359.31 | 2,565.36 | 2,648.96 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | -2.89 | -12.05 | 28.16 | 28.16 |
| P & L Balance carried down | 2,602.59 | 2,445.03 | 2,279.18 | 2,359.31 | 2,565.36 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 200.00 | 200.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 4.00 | 4.00 |
| Earnings Per Share-Unit Curr | 22.58 | 23.15 | -13.09 | -42.57 | -7.87 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 373.17 | 349.40 | 325.94 | 338.65 | 379.52 |
| Book Value(Adj)-Unit Curr | 373.17 | 349.40 | 325.94 | 338.65 | 379.52 |
